AzTrials
AzTrials

Nutritional StatusMEDICANUT2NCT02894827

The Effect of When Medication is Taken on Nutritional Status in Hospitalized Patients Older Than 65 Years

An observational study of Nutritional Status, run by Centre Hospitalier Universitaire Dijon at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Polypathology in elderly subjects requires polypharmacy but even though the efficacy of a medication and digestive tolerance are ensured, the medication can be taken a long time from meals to reduce its side-effects. Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Nutritional Status
What is being tested?
Blood sample, Flow cytometry and western blot
How many people
30 participants
Where
1 siteFrance
Study dates
Start not givento Sep 2015
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Study population: patients with a stable or controlled acute disease hospitalized in a geriatric follow-up care unit

Who may be able to join

  • patients aged 65 years or more.
  • patients with a stable or controlled acute disease hospitalized in a geriatric follow-up care unit.
  • patients whose life expectancy is greater than 30 days.
  • patients able to eat food normally.
  • patients able to swallow their medication.
  • patients with at least 3 drugs to be taken orally per day, not including oral nutritional supplements.

Who cannot join

  • patients at the end of life.
  • patients whose drugs must be taken before meals like Non-steroid anti-inflammatory drugs (NSAIDs), glinides, oral antidiabetic agents (OAD).
  • patients with parenteral and/or enteral nutrition in the period preceding admission to the geriatric unit.
  • patients with indications for parental and/or enteral nutrition.

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU Dijon Bourgogne

    Dijon, 21079

Other trials in France

About this study

Polypathology in elderly subjects requires polypharmacy but even though the efficacy of a medication and digestive tolerance are ensured, the medication can be taken a long time from meals to reduce its side-effects. Despite numerous studies that have investigated links between medication and malnutrition, none have assessed the influence of the time the drug is taken on the evolution of the nutritional status of elderly hospitalized persons. So as to identify the best nutritional criterion in hospitalized persons, a retrospective pilot study will be conducted in about thirty patients. Their medication will be recorded and their nutritional status will be evaluated using the Geriatric Nutritional Risk Index (GNRI), albumin, prealbumin levels, weight and the Mini Nutritional Assessment (MNA) short form.

This preliminary study will allow us to choose the best nutritional criterion to compare the impact of two strategies for taking medication (post prandial versus pre-prandial) on improving the nutritional status of malnourished elderly hospitalized patients taking multiple drugs.

Being tested
Blood sample, Flow cytometry, western blot

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT02894827
Study groupRoleWhat they receive
EMSNot described
Receives: Biological: Blood sample; Other: Flow cytometry; Other: western blot
ControlNot described
Receives: Biological: Blood sample; Other: Flow cytometry; Other: western blot

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. MNA short form

    Measured: 30 days

Secondary outcomes (1)
  1. Geriatric Nutritional risk form

    Measured: 30 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Sep 2016 (estimated)
  2. Primary completionSep 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Retrospective
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02894827
Sponsor's protocol ID
VAN WYMELBEKE 2015
Acronym
MEDICANUT2
Status last verified
Sep 2016
First submitted
31 Aug 2016
Last updated
9 Sep 2016
Results posted
No

Questions about this trial

What is this clinical trial studying?

An observational study of Nutritional Status, run by Centre Hospitalier Universitaire Dijon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Sep 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

MNA short form (time frame: 30 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Sep 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in